InnovAge Capex To Revenue vs Ebit Per Revenue Analysis

INNV Stock

USD 3.95 0.22 5.90%

InnovAge Holding financial indicator trend analysis is infinitely more than just investigating InnovAge Holding Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InnovAge Holding Corp is a good investment. Please check the relationship between InnovAge Holding Capex To Revenue and its Ebit Per Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InnovAge Holding Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Capex To Revenue vs Ebit Per Revenue

Capex To Revenue vs Ebit Per Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InnovAge Holding Corp Capex To Revenue account and Ebit Per Revenue. At this time, the significance of the direction appears to have very week relationship.

The correlation between InnovAge Holding's Capex To Revenue and Ebit Per Revenue is 0.26. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Ebit Per Revenue in the same time period over historical financial statements of InnovAge Holding Corp, assuming nothing else is changed. The correlation between historical values of InnovAge Holding's Capex To Revenue and Ebit Per Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of InnovAge Holding Corp are associated (or correlated) with its Ebit Per Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit Per Revenue has no effect on the direction of Capex To Revenue i.e., InnovAge Holding's Capex To Revenue and Ebit Per Revenue go up and down completely randomly.

Correlation Coefficient

0.26

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Ebit Per Revenue

Most indicators from InnovAge Holding's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InnovAge Holding Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InnovAge Holding Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, InnovAge Holding's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 606.83 in 2025, whereas Selling General Administrative is likely to drop slightly above 65.7 M in 2025.

	2022	2023	2024	2025 (projected)
Gross Profit	101.3M	132.1M	151.9M	88.7M
Total Revenue	688.1M	763.9M	878.4M	922.4M

Gross Profit Total Revenue

InnovAge Holding fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Good Will	Inventory	Other Current Assets	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt
Total Assets		0.89	0.91	0.95	0.78	0.78	-0.06	0.91	0.84	0.93	0.42	0.87	0.99	-0.35	0.85	0.93	0.96	0.98	0.77	0.71	0.89	0.93	-0.8	0.82	-0.15	-0.77
Other Current Liab	0.89		0.99	0.84	0.64	0.85	-0.33	0.99	0.66	0.95	0.34	0.92	0.89	-0.64	0.97	0.83	0.88	0.84	0.94	0.63	0.8	0.98	-0.81	0.87	-0.16	-0.61
Total Current Liabilities	0.91	0.99		0.84	0.62	0.82	-0.3	0.99	0.66	0.96	0.37	0.9	0.9	-0.6	0.96	0.86	0.89	0.85	0.94	0.65	0.82	0.98	-0.79	0.88	-0.05	-0.61
Total Stockholder Equity	0.95	0.84	0.84		0.76	0.9	-0.19	0.85	0.86	0.82	0.21	0.73	0.9	-0.37	0.86	0.76	0.93	0.96	0.77	0.65	0.8	0.91	-0.93	0.85	-0.1	-0.9
Other Liab	0.78	0.64	0.62	0.76		0.62	0.22	0.62	0.86	0.68	0.46	0.7	0.78	0.07	0.57	0.71	0.73	0.85	0.45	0.77	0.74	0.69	-0.63	0.43	-0.59	-0.76
Net Tangible Assets	0.78	0.85	0.82	0.9	0.62		-0.5	0.84	0.7	0.72	-0.01	0.63	0.7	-0.58	0.93	0.53	0.79	0.79	0.87	0.51	0.62	0.89	-0.98	0.87	-0.1	-0.83
Retained Earnings	-0.06	-0.33	-0.3	-0.19	0.22	-0.5		-0.3	0.24	-0.08	0.38	0.0	0.01	0.77	-0.49	0.13	-0.16	0.05	-0.59	0.05	0.02	-0.28	0.42	-0.59	-0.19	0.03
Accounts Payable	0.91	0.99	0.99	0.85	0.62	0.84	-0.3		0.68	0.96	0.36	0.92	0.9	-0.62	0.96	0.84	0.89	0.86	0.93	0.65	0.81	0.99	-0.82	0.87	-0.08	-0.64
Cash	0.84	0.66	0.66	0.86	0.86	0.7	0.24	0.68		0.74	0.37	0.67	0.79	0.05	0.62	0.71	0.78	0.93	0.48	0.69	0.74	0.76	-0.75	0.5	-0.18	-0.93
Other Assets	0.93	0.95	0.96	0.82	0.68	0.72	-0.08	0.96	0.74		0.5	0.96	0.95	-0.44	0.87	0.93	0.91	0.89	0.83	0.71	0.86	0.95	-0.73	0.76	-0.09	-0.62
Long Term Debt	0.42	0.34	0.37	0.21	0.46	-0.01	0.38	0.36	0.37	0.5		0.56	0.5	0.25	0.18	0.62	0.4	0.42	0.15	0.55	0.36	0.31	0.0	0.06	-0.23	-0.1
Net Receivables	0.87	0.92	0.9	0.73	0.7	0.63	0.0	0.92	0.67	0.96	0.56		0.91	-0.43	0.81	0.91	0.84	0.82	0.75	0.68	0.83	0.89	-0.62	0.66	-0.28	-0.51
Good Will	0.99	0.89	0.9	0.9	0.78	0.7	0.01	0.9	0.79	0.95	0.5	0.91		-0.34	0.81	0.97	0.95	0.95	0.74	0.71	0.9	0.91	-0.72	0.77	-0.21	-0.68
Inventory	-0.35	-0.64	-0.6	-0.37	0.07	-0.58	0.77	-0.62	0.05	-0.44	0.25	-0.43	-0.34		-0.71	-0.27	-0.36	-0.22	-0.79	-0.03	-0.29	-0.56	0.49	-0.75	-0.11	0.08
Other Current Assets	0.85	0.97	0.96	0.86	0.57	0.93	-0.49	0.96	0.62	0.87	0.18	0.81	0.81	-0.71		0.72	0.85	0.8	0.98	0.56	0.73	0.97	-0.89	0.93	-0.06	-0.66
Total Liab	0.93	0.83	0.86	0.76	0.71	0.53	0.13	0.84	0.71	0.93	0.62	0.91	0.97	-0.27	0.72		0.87	0.88	0.67	0.69	0.88	0.83	-0.54	0.66	-0.18	-0.52
Short Long Term Debt	0.96	0.88	0.89	0.93	0.73	0.79	-0.16	0.89	0.78	0.91	0.4	0.84	0.95	-0.36	0.85	0.87		0.93	0.78	0.7	0.87	0.92	-0.84	0.83	-0.09	-0.75
Total Current Assets	0.98	0.84	0.85	0.96	0.85	0.79	0.05	0.86	0.93	0.89	0.42	0.82	0.95	-0.22	0.8	0.88	0.93		0.7	0.73	0.86	0.91	-0.82	0.73	-0.18	-0.86
Short Term Debt	0.77	0.94	0.94	0.77	0.45	0.87	-0.59	0.93	0.48	0.83	0.15	0.75	0.74	-0.79	0.98	0.67	0.78	0.7		0.48	0.66	0.92	-0.81	0.94	-0.01	-0.52
Intangible Assets	0.71	0.63	0.65	0.65	0.77	0.51	0.05	0.65	0.69	0.71	0.55	0.68	0.71	-0.03	0.56	0.69	0.7	0.73	0.48		0.79	0.66	-0.55	0.45	-0.18	-0.59
Common Stock	0.89	0.8	0.82	0.8	0.74	0.62	0.02	0.81	0.74	0.86	0.36	0.83	0.9	-0.29	0.73	0.88	0.87	0.86	0.66	0.79		0.82	-0.64	0.67	-0.18	-0.62
Property Plant Equipment	0.93	0.98	0.98	0.91	0.69	0.89	-0.28	0.99	0.76	0.95	0.31	0.89	0.91	-0.56	0.97	0.83	0.92	0.91	0.92	0.66	0.82		-0.88	0.88	-0.08	-0.74
Short Long Term Debt Total	-0.8	-0.81	-0.79	-0.93	-0.63	-0.98	0.42	-0.82	-0.75	-0.73	0.0	-0.62	-0.72	0.49	-0.89	-0.54	-0.84	-0.82	-0.81	-0.55	-0.64	-0.88		-0.84	0.03	0.89
Property Plant And Equipment Net	0.82	0.87	0.88	0.85	0.43	0.87	-0.59	0.87	0.5	0.76	0.06	0.66	0.77	-0.75	0.93	0.66	0.83	0.73	0.94	0.45	0.67	0.88	-0.84		0.06	-0.59
Current Deferred Revenue	-0.15	-0.16	-0.05	-0.1	-0.59	-0.1	-0.19	-0.08	-0.18	-0.09	-0.23	-0.28	-0.21	-0.11	-0.06	-0.18	-0.09	-0.18	-0.01	-0.18	-0.18	-0.08	0.03	0.06		0.08
Net Debt	-0.77	-0.61	-0.61	-0.9	-0.76	-0.83	0.03	-0.64	-0.93	-0.62	-0.1	-0.51	-0.68	0.08	-0.66	-0.52	-0.75	-0.86	-0.52	-0.59	-0.62	-0.74	0.89	-0.59	0.08

Click cells to compare fundamentals

InnovAge Holding Account Relationship Matchups

InnovAge Holding fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	531.8M	555.6M	567.4M	547.7M	629.8M	330.1M
Other Current Liab	38.3M	44.2M	47.2M	61.9M	71.1M	74.7M
Total Current Liabilities	78.6M	105.3M	148.5M	138.6M	159.4M	167.4M
Total Stockholder Equity	335.1M	332.4M	296.3M	269.3M	309.7M	155.0M
Other Liab	7.2M	10.7M	18.9M	7.3M	8.4M	7.6M
Net Tangible Assets	(48.9M)	(20.3M)	202.3M	166.9M	191.9M	201.5M
Retained Earnings	11.3M	4.7M	(35.9M)	(68.3M)	(61.5M)	(58.4M)
Accounts Payable	32.4M	50.6M	44.6M	55.5M	63.8M	67.0M
Cash	201.5M	184.4M	127.2M	56.9M	65.5M	82.0M
Other Assets	4.1M	3.0M	2.8M	3.8M	4.4M	4.6M
Long Term Debt	210.4M	68.2M	64.8M	61.5M	70.7M	80.3M
Net Receivables	38.0M	42.7M	24.6M	51.4M	59.1M	62.1M
Good Will	117.3M	116.1M	124.2M	139.9M	160.9M	82.4M
Inventory	2.2M	1.0	(262K)	(3.3M)	(3.0M)	(2.8M)
Other Current Assets	11.5M	13.9M	17.2M	18.9M	21.8M	22.9M
Total Liab	173.8M	201.9M	252.6M	247.9M	285.0M	163.3M
Short Long Term Debt	3.3M	1.9M	3.8M	3.8M	4.4M	2.7M
Total Current Assets	250.9M	241.0M	215.2M	173.1M	199.1M	129.1M
Short Term Debt	7.9M	10.5M	20.3M	21.3M	24.5M	25.7M
Intangible Assets	6.5M	5.9M	5.2M	4.5M	5.2M	5.4M
Property Plant Equipment	101.2M	102.5M	176.3M	213.4M	245.4M	257.7M
Short Long Term Debt Total	82.6M	84.8M	108.8M	113.0M	101.7M	106.9M
Property Plant And Equipment Net	142.7M	176.3M	213.4M	221.4M	254.7M	175.5M
Current Deferred Revenue	12.2M	7.1M	28.1M	15.2M	17.5M	18.3M
Net Debt	(118.8M)	(99.6M)	(18.4M)	56.1M	50.5M	53.0M
Non Current Assets Total	280.8M	314.6M	352.1M	374.5M	430.7M	331.6M
Non Currrent Assets Other	(3.0M)	(4.5M)	(1K)	5.9M	5.4M	5.6M
Cash And Short Term Investments	201.5M	184.4M	173.5M	102.8M	118.2M	153.0M
Common Stock Shares Outstanding	135.5M	135.5M	135.6M	135.9M	156.3M	148.3M
Liabilities And Stockholders Equity	531.8M	555.6M	567.4M	547.7M	629.8M	545.5M
Non Current Liabilities Total	95.2M	96.5M	104.1M	109.3M	98.3M	110.5M
Capital Lease Obligations	5.6M	12.8M	40.2M	47.8M	54.9M	28.0M
Other Stockholder Equity	323.8M	327.5M	332.1M	337.4M	388.1M	255.3M
Net Invested Capital	313.4M	404.4M	364.9M	334.5M	384.7M	374.9M
Property Plant And Equipment Gross	233.3M	213.4M	284.1M	308.9M	355.2M	227.9M
Non Current Liabilities Other	1.4M	1.1M	1.1M	1.3M	1.2M	950.1K
Net Working Capital	90.3M	135.6M	66.8M	34.5M	31.1M	57.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for InnovAge Stock Analysis

When running InnovAge Holding's price analysis, check to measure InnovAge Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnovAge Holding is operating at the current time. Most of InnovAge Holding's value examination focuses on studying past and present price action to predict the probability of InnovAge Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnovAge Holding's price. Additionally, you may evaluate how the addition of InnovAge Holding to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC